Results 171 to 180 of about 39,999 (253)
ABSTRACT In older patients receiving mavacamten, a reduction in NT‐proBNP levels may coexist with persistent severe LVOTO. Nurses should interpret this biomarker–echocardiography discordance as a safety signal and maintain structured cardiovascular surveillance rather than assuming treatment success based solely on biomarker improvement.
Feifei Wang
wiley +1 more source
The Efficacy of Ambulatory Blood Pressure Monitoring-Derived Indices in Predicting Organ Damage in Patients With Hypertension. [PDF]
Candemir M +3 more
europepmc +1 more source
ABSTRACT Mucopolysaccharidosis should be suspected in patients presenting with multisystem involvement, including coarse facial features, skeletal abnormalities, and progressive organ dysfunction, particularly in resource‐limited settings where delayed diagnosis is common.
Alaa Bella +11 more
wiley +1 more source
Ambulatory Blood Pressure Monitoring During 52 Hours in Patients With Chronic Kidney Disease and Haemodialysis Treatment-An Exploratory Pilot Study. [PDF]
Stenberg J +3 more
europepmc +1 more source
ABSTRACT High‐energy open chest injuries with lung evisceration may be associated with concurrent injuries and serious potential sequelae including pneumocranium, brachial plexus injury, and venous thrombosis. Early resuscitation, adherence to ATLS principles, and coordinated multidisciplinary care are critical for survival and functional outcomes ...
Brian Kasagga +10 more
wiley +1 more source
Ambulatory blood pressure monitoring in Egyptian children with nephrotic syndrome: single center experience. [PDF]
Alazem EAA +3 more
europepmc +1 more source
This study retrospectively analyzed the characteristics of blood pressure rhythm after emergency PCI for patients with anterior STEMI, discovering the burden of disrupted BP circadian rhythm. The reverse dipper BP rhythm may serve as an independent factor of MACE.
Yangge Shao +4 more
wiley +1 more source
Chronic kidney disease stages and changes in ambulatory blood pressure monitoring: letter to the editor. [PDF]
Daungsupawong H, Wiwanitkit V.
europepmc +1 more source
ABSTRACT Desmopressin is first‐line therapy for central diabetes insipidus, also known as arginine vasopressin deficiency, but presents dosing challenges due to its narrow therapeutic index. This open‐label, randomized, three‐way crossover study evaluated the bioequivalence of a new desmopressin acetate oral solution (50 mcg/mL) compared to ...
Adam Christensen +5 more
wiley +1 more source

